To present the critical points concerning organizational and economic issues of the introduction of boceprevir in the treatment of patients with genotype 1 chronic hepatitis C in Italy.
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy / LA TORRE, G., Miele, L., Mannocci, A., Saulle, R., Giraldi, G., Unim, B.A., Ursillo, P., Semyonov, L., Colamesta, V., Melcarne, R., Biolato, M., Cecchi, R., Villari, P., DE GIUSTI, M.. - In: VALUE IN HEALTH. - ISSN 1524-4733. - STAMPA. - 16:7(2013), pp. 494-495. (ISPOR 16th Annual European Congress and 4th Latin America Conference Research Abstracts Dublin; Ireland ) [10.1016/S1098-3015(13)04244-7].
Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy
LA TORRE, Giuseppe;Miele, Luca;MANNOCCI, ALICE;SAULLE, ROSELLA;GIRALDI, GUGLIELMO;UNIM, BRIGID ANDOUNIMYE;URSILLO, PAOLO;SEMYONOV, LEDA;COLAMESTA, VITTORIA;Melcarne, R.;CECCHI, Rossana;VILLARI, Paolo;DE GIUSTI, Maria
2013
Abstract
To present the critical points concerning organizational and economic issues of the introduction of boceprevir in the treatment of patients with genotype 1 chronic hepatitis C in Italy.| File | Dimensione | Formato | |
|---|---|---|---|
|
LaTorre_Organizational_2013.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
79.6 kB
Formato
Adobe PDF
|
79.6 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
